ReNeu: A Pivotal Phase 2b Trial of Mirdametinib in Children and Adults With Neurofibromatosis Type 1 (NF1)-Associated Symptomatic Plexiform Neurofibroma (PN) (S29.003)

Hans Shuhaiber; Christopher Moertel; Angela Hirbe; David Viskochil; Alpa Sidhu; Kevin Bielamowicz; Michael Weber; Armend Lokku; L. Mary Smith; Lauren Weintraub; Rene McNall-Knapp; Fouad Hajjar; Nicholas Foreman; Timothy Gershon; Dusica Babovic-Vuksanovic

doi:10.1212/WNL.0000000000209005

Back

ReNeu: A Pivotal Phase 2b Trial of Mirdametinib in Children and Adults With Neurofibromatosis Type 1 (NF1)-Associated Symptomatic Plexiform Neurofibroma (PN) (S29.003)

Abstract

Peer reviewed

ReNeu: A Pivotal Phase 2b Trial of Mirdametinib in Children and Adults With Neurofibromatosis Type 1 (NF1)-Associated Symptomatic Plexiform Neurofibroma (PN) (S29.003)

Hans Shuhaiber, Christopher Moertel, Angela Hirbe, David Viskochil, Alpa Sidhu, Kevin Bielamowicz, Michael Weber, Armend Lokku, L. Mary Smith, Lauren Weintraub, …

Neurology, Vol.104(7_Supplement_1)

04/08/2025

DOI: 10.1212/WNL.0000000000209005

View Online

Abstract

Abstract only

Details

Title: Subtitle: ReNeu: A Pivotal Phase 2b Trial of Mirdametinib in Children and Adults With Neurofibromatosis Type 1 (NF1)-Associated Symptomatic Plexiform Neurofibroma (PN) (S29.003)
Creators: Hans Shuhaiber
Christopher Moertel
Angela Hirbe
David Viskochil
Alpa Sidhu
Kevin Bielamowicz
Michael Weber
Armend Lokku
L. Mary Smith
Lauren Weintraub
Rene McNall-Knapp
Fouad Hajjar
Nicholas Foreman
Timothy Gershon
Dusica Babovic-Vuksanovic
Resource Type: Abstract
Publication Details: Neurology, Vol.104(7_Supplement_1)
DOI: 10.1212/WNL.0000000000209005
ISSN: 0028-3878
eISSN: 1526-632X
Language: English
Date published: 04/08/2025
Academic Unit: Medical Genetics and Genomics; Stead Family Department of Pediatrics
Record Identifier: 9984808526302771

Metrics

1 Record Views

See more details